MARKET

MXCT

MXCT

Maxcyte
NASDAQ
1.270
+0.080
+6.72%
After Hours: 1.300 +0.03 +2.36% 19:39 06/25 EDT
OPEN
1.210
PREV CLOSE
1.190
HIGH
1.285
LOW
1.205
VOLUME
2.27M
TURNOVER
--
52 WEEK HIGH
2.370
52 WEEK LOW
0.6434
MARKET CAP
136.04M
P/E (TTM)
-3.4614
1D
5D
1M
3M
1Y
5Y
1D
Craig-Hallum Keeps Their Buy Rating on MaxCyte (MXCT)
TipRanks · 17h ago
Weekly Report: what happened at MXCT last week (0615-0619)?
Weekly Report · 3d ago
Craig-Hallum Reaffirms Their Buy Rating on MaxCyte (MXCT)
TipRanks · 06/18 09:15
MaxCyte Shareholders Reelect Directors and Ratify Auditor
TipRanks · 06/17 22:31
MaxCyte shareholders approve CohnReznick as independent auditor for fiscal 2026
PUBT · 06/17 21:00
MaxCyte Regains Nasdaq Compliance After Bid Price Recovery
TipRanks · 06/16 21:15
MaxCyte regains Nasdaq compliance after shares trade above $1 for 10 days
PUBT · 06/16 20:22
Weekly Report: what happened at MXCT last week (0608-0612)?
Weekly Report · 06/15 09:17
More
About MXCT
MaxCyte, Inc. is a cell-engineering focused company providing solutions to advance the discovery, development and commercialization of cell therapeutics. It leverages its cell engineering technology platform to enable the programs of its biotechnology and pharmaceutical company customers who are engaged in cell therapy. Its ExPERT platform, which is based on its Flow Electroporation technology, is designed to support the expanding cell therapy market and can be utilized across the continuum of the cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes four instruments, the ATx, STx, GTx and VLx; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a worldwide intellectual property portfolio. It also provides comprehensive off-target risk assessment solutions for gene editing, through ONE-seq and GUIDE-seq platforms.

Webull offers MaxCyte Inc stock information, including NASDAQ: MXCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MXCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MXCT stock methods without spending real money on the virtual paper trading platform.